NephroPlus IPO
Healthcare/Dialysis - Listed on 17 December 2025
NephroPlus IPO listing summary
NephroPlus (Healthcare/Dialysis) closed its IPO window in 2025 and listed on NSE and BSE on 17 December 2025 at an upper band issue price of Rs 460, opening at Rs 490 for a listing gain of +6.5% and closing day one at Rs 471.25 (+2.4% on closing basis). The IPO was subscribed 13.96x overall - QIB 27.47x, HNI/NII 24.27x, Retail 2.31x. The total issue size was Rs 871.05 Cr (Fresh Issue Rs 353.41 Cr, OFS Rs 517.64 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Listing day performance
Subscription breakdown
Final (Day 3) subscription
Number of times each investor category subscribed by close of Day 3.
Day-wise overall subscription
How overall subscription built up across the three-day issue window.
NephroPlus IPO GMP history
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | Rs 25 | +5.43% |
| Day 2 | Rs 25 | +5.43% |
| Day 3 | Rs 25 | +5.43% |
| Day 4 | Rs 25 | +5.43% |
| Day 5 | Rs 25 | +5.43% |
GMP Prediction vs IPOGyani AI Prediction
Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.
Issue & financials
Market context at listing
How the broader market moved around the NephroPlus IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
NephroPlus IPO - FAQs
What was the listing gain of NephroPlus IPO?
NephroPlus IPO listed at +6.5% versus the upper issue price of Rs 460 on 17 December 2025.
How many times was NephroPlus IPO subscribed?
NephroPlus IPO was subscribed 13.96x overall. QIB portion was subscribed 27.47x, HNI / NII 24.27x and Retail 2.31x.
What was the IPO GMP for NephroPlus?
IPO GMP started at Rs 25 on Day 1 and moved to Rs 25 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.